2002
DOI: 10.1172/jci0216242
|View full text |Cite
|
Sign up to set email alerts
|

NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele

Abstract: Mutations in NPHS2, encoding podocin, have been identified in childhood onset focal and segmental glomerulosclerosis (FSGS). The role of NPHS2 in adult disease is less well defined. We studied 30 families with FSGS and apparent autosomal recessive inheritance and 91 individuals with primary FSGS. We screened family members for NPHS2 mutations. NPHS2 mutations appeared to be responsible for disease in nine of these families. In six families, the affected individuals were compound heterozygotes for a nonconserva… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
141
1
3

Year Published

2007
2007
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 191 publications
(156 citation statements)
references
References 31 publications
11
141
1
3
Order By: Relevance
“…Interestingly, the alpha actinin 4 mRNA is underexpressed in the glomeruli of patients with microalbuminuria compared with patients with normal AER [10]. In addition, a combination of glucose and advanced glycation end-products reduced the expression of alpha actinin-4 at both the protein and the Table 1 c Patients homozygous for the minor allele (2/2) were compared with patients homozygous for the major allele (1/1) d The non-synonymous R229Q SNP in NPHS2 characterised by Tsukaguchi et al [13] was included mRNA level in podocytes in vitro [11]. Whether or not the observed variation in ACTN4 represents a true association remains to be determined in replication studies in other populations.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, the alpha actinin 4 mRNA is underexpressed in the glomeruli of patients with microalbuminuria compared with patients with normal AER [10]. In addition, a combination of glucose and advanced glycation end-products reduced the expression of alpha actinin-4 at both the protein and the Table 1 c Patients homozygous for the minor allele (2/2) were compared with patients homozygous for the major allele (1/1) d The non-synonymous R229Q SNP in NPHS2 characterised by Tsukaguchi et al [13] was included mRNA level in podocytes in vitro [11]. Whether or not the observed variation in ACTN4 represents a true association remains to be determined in replication studies in other populations.…”
Section: Discussionmentioning
confidence: 99%
“…[Arg229Gln];[mut] that causes SRNS with a median age at diagnosis of 13 years (range, 0-39 years) and progression to ESRD by 26 years (range, 10-50 years) 7,[13][14][15][16][17][18] . Nevertheless, the p.Arg229Gln variant in the homozygous state does not cause SRNS 19,20 .…”
Section: Introductory Paragraphmentioning
confidence: 99%
“…Nevertheless, the high allele frequency of p.Arg229Gln in late onset SRNS (5.7-7.5%) [16][17][18] points to its pathogenicity in some cases. Recognizing that this discrepancy could reflect the influence of the trans-associated mutations, we compared the exonic localization of the mutations between cases with [mut]; [mut] and cases with p.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…3-9 The polymorphism R229Q is one of the most commonly reported podocin sequence variations, and has repeatedly been found with slightly increased frequency in SRNS and FSGS cases compared to healthy controls. 5,8,10 The arginine (R) residue at protein position 229 is highly conserved across species, and the arginine-toglutamine substitution R229Q (p.229Arg>Glu, corresponding to the nucleotide substitution g. 686G>A) has been reported to alter functional properties of podocin in vitro 5 and possibly in vivo. 11…”
Section: Introductionmentioning
confidence: 99%